NCT05324137View on ClinicalTrials.gov

A Study of CM326 in Patients With Chronic Rhinosinusitis With Nasal Polyps

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

88

Participants

Timeline

Start Date

July 11, 2022

Primary Completion Date

March 29, 2024

Study Completion Date

March 29, 2024

Conditions
Chronic Rhinosinusitis With Nasal Polyps
Interventions
DRUG

CM326

CM326 injection

OTHER

Placebo

Placebo

Trial Locations (1)

Unknown

Beijing Tongren Hospital, CMU, Beijing

Sponsors
All Listed Sponsors
lead

Keymed Biosciences Co.Ltd

INDUSTRY

NCT05324137 - A Study of CM326 in Patients With Chronic Rhinosinusitis With Nasal Polyps | Biotech Hunter | Biotech Hunter